Publication | Closed Access
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study
33
Citations
12
References
2019
Year
Hematological MalignancySingle-agent DaratumumabMedicineImmunologyImmune Checkpoint InhibitorImmunotherapyOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1